Studs Terkel interviews two representatives from Abbott Laboratories: Richard Kasperson, V.P. of corporate regulatory affairs, and Dr. Robert Janicki, V.P. of corporate clinical research. The topic of conversation is the prescribed use of Cylert, which was a trade name for the drug Pemoline. Cylert was used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. Janicki and Kasperson respond to claims that the drug was overprescribed to school-aged children.